Goeltz II Robert C. 4
4 · Arcus Biosciences, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-12-31$15.00/sh−3,594$53,910→ 60,138 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023.